The impact of alternative splicing in vivo: Mouse models show the way

RNA

Volumn 13, Issue 8, 2007, Pages 1155-1171

  Möröy, Tarik ^a   Heyd, Florian ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Alternative splicing; Mouse models

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AGRIN; CD45 ANTIGEN; CELL SURFACE RECEPTOR; DOPAMINE 2 RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBRONECTIN; GROWTH FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; INTEGRIN; ISOPROTEIN; LIGAND; PLECTIN; RNA BINDING PROTEIN; SCAVENGER RECEPTOR; SCLEROPROTEIN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; STAT3 PROTEIN; TRANSCRIPTION FACTOR PAX6; VASCULOTROPIN; WT1 PROTEIN;

ALTERNATIVE RNA SPLICING; CRYSTALLIZATION; GENE DELETION; GENE DISRUPTION; GENE OVEREXPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; KNOCKOUT MOUSE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; REVIEW; SARCOPLASMIC RETICULUM;

MAMMALIA; MUS;

EID: 34447539875     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.554607     Document Type: Review

References (128)

1. Abrahamsberg, C., Fuchs, P., Osmanagic-Myers, S., Fischer, I., Propst, F., Elbe-Burger, A., and Wiche, G. 2005. Targeted ablation of plectin isoform 1 uncovers role of cytolinker proteins in leukocyte recruitment. Proc. Natl. Acad. Sci. 102: 18449-18454.
2. 2+ loads only. Circ. Res. 92: 881-887.
3. Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J.K., and Lonai, P. 1998. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. 95: 5082-5087.
4. Baraniak, A.P., Chen, J.R., and Garcia-Blanco, M.A. 2006. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Mol. Cell. Biol. 26: 1209-1222.
5. Baudoin, C., Goumans, M.J., Mummery, C., and Sonnenberg, A. 1998. Knockout and knockin of the β1 exon D define distinct roles for integrin splice variants in heart function and embryonic development. Genes & Dev. 12: 1202-1216.
6. Black, D.L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72: 291-336.
7. Blencowe, B.J. 2006. Alternative splicing: New insights from global analyses. Cell 126: 37-47.
8. Bonano, V.I., Oltean, S., Brazas, R.M., and Garcia-Blanco, M.A. 2006. Imaging the alternative silencing of FGFR2 exon IIIb in vivo. RNA 12: 2073-2079.
9. Branda, C.S. and Dymecki, S.M. 2004. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 6: 7-28.
10. Buchner, D.A., Trudeau, M., and Meisler, M.H. 2003. SCNM1, a putative RNA splicing factor that modifies disease severity in mice. Science 301: 967-969.
11. Burgess, R.W., Nguyen, Q.T., Son, Y.J., Lichtman, J.W., and Sanes, J.R. 1999. Alternatively spliced isoforms of nerve- and muscle-derived agrin: Their roles at the neuromuscular junction. Neuron 23: 33-44.
12. + thymocytes, and B cell maturation. J. Exp. Med. 183: 1707-1718.
13. Cachaco, A.S., Chuva de Sousa Lopes, S.M., Kuikman, I., Bajanca, F., Abe, K., Baudoin, C., Sonnenberg, A., Mummery, C.L., and Thorsteinsdottir, S. 2003. Knock-in of integrin β 1D affects primary but not secondary myogenesis in mice. Development 130: 1659-1671.
14. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
15. Carmeliet, P., Ng, Y.S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V.V., Stalmans, I., Mattot, V., et al. 1999. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5: 495-502.
16. Cartegni, L., Chew, S.L., and Krainer, A.R. 2002. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3: 285-298.
17. Chauhan, A.K., Iaconcig, A., Baralle, F.E., and Muro, A.F. 2004. Alternative splicing of fibronectin: A mouse model demonstrates the identity of in vitro and in vivo systems and the processing autonomy of regulated exons in adult mice. Gene 324: 55-63.
18. Chauhan, A.K., Moretti, F.A., Iaconcig, A., Baralle, F.E., and Muro, A.F. 2005. Impaired motor coordination in mice lacking the EDA exon of the fibronectin gene. Behav. Brain Res. 161: 31-38.
19. Crenshaw 3rd, E.B., Russo, A.F., Swanson, L.W., and Rosenfeld, M.G. 1987. Neuron-specific alternative RNA processing in transgenic mice expressing a metallothionein-calcitonin fusion gene. Cell 49: 389-398.
20. Danen, E.H. and Sonnenberg, A. 2003. Integrins in regulation of tissue development and function. J. Pathol. 201: 632-641.
21. De Moerlooze, L., Spencer-Dene, B., Revest, J., Hajihosseini, M., Rosewell, I., and Dickson, C. 2000. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127: 483-492.
22. Dev, A., Nayernia, K., Meins, M., Adham, I., Lacone, F., and Engel, W. 2007. Mice deficient for RNA-binding protein brunol1 show reduction of spermatogenesis but are fertile. Mol. Reprod. Dev. doi: 10.1002/mrd.20742.
23. Ding, J.H., Xu, X., Yang, D., Chu, P.H., Dalton, N.D., Ye, Z., Yeakley, J.M., Cheng, H., Xiao, R.P., Ross, J., et al. 2004. Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart. EMBO J. 23: 885-896.
24. Domanico, S.Z., Pelletier, A.J., Havran, W.L., and Quaranta, V. 1997. Integrin α 6A β 1 induces CD81-dependent cell motility without engaging the extracellular matrix migration substrate. Mol. Biol. Cell 8: 2253-2265.
25. Duan, Z., Zarebski, A., Montoya-Durango, D., Grimes, H.L., and Horwitz, M. 2005. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol. Cell. Biol. 25: 10338-10351.
26. Ellis, P.D., Smith, C.W., and Kemp, P. 2004. Regulated tissue-specific alternative splicing of enhanced green fluorescent protein transgenes conferred by α-tropomyosin regulatory elements in transgenic mice. J. Biol. Chem. 279: 36660-36669.
27. Epstein, J.A., Glaser, T., Cai, J., Jepeal, L., Walton, D.S., and Maas, R.L. 1994. Two independent and interactive DNA-binding subdomains of the Pax6 paired domain are regulated by alternative splicing. Genes & Dev. 8: 2022-2034.
28. Faustino, N.A. and Cooper, T.A. 2003. Pre-mRNA splicing and human disease. Genes & Dev. 17: 419-437.
29. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J., and Moore, M.W. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
30. Fiolka, K., Hertzano, R., Vassen, L., Zeng, H., Hermesh, O., Avraham, K.B., Duhrsen, U., and Moroy, T. 2006. Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development. EMBO Rep. 7: 326-333.
31. Floyd, J.A., Gold, D.A., Concepcion, D., Poon, T.H., Wang, X., Keithley, E., Chen, D., Ward, E.J., Chinn, S.B., Friedman, R.A., et al. 2003. A natural allele of Nxf1 suppresses retrovirus insertional mutations. Nat. Genet. 35: 221-228.
32. Fukuda, T., Yoshida, N., Kataoka, Y., Manabe, R., Mizuno-Horikawa, Y., Sato, M., Kuriyama, K., Yasui, N., and Sekiguchi, K. 2002. Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res. 62: 5603-5610.
33. Gautam, M., Noakes, P.G., Moscoso, L., Rupp, F., Scheller, R.H., Merlie, J.P., and Sanes, J.R. 1996. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85: 525-535.
34. Gebski, B.L., Mann, C.J., Fletcher, S., and Wilton, S.D. 2003. Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. Hum. Mol. Genet. 12: 1801-1811.
35. George, E.L., Georges-Labouesse, E.N., Patel-King, R.S., Rayburn, H., and Hynes, R.O. 1993. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119: 1079-1091.
36. Gimond, C., Baudoin, C., van der Neut, R., Kramer, D., Calafat, J., and Sonnenberg, A. 1998. Cre-loxP-mediated inactivation of the α6A integrin splice variant in vivo: Evidence for a specific functional role of α6A in lymphocyte migration but not in heart development. J. Cell Biol. 143: 253-266.
37. Guiramand, J., Montmayeur, J.P., Ceraline, J., Bhatia, M., and Borrelli, E. 1995. Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins. J. Biol. Chem. 270: 7354-7358.
38. Guo, H. and Wang, C.L. 2005. Specific disruption of smooth muscle caldesmon expression in mice. Biochem. Biophys. Res. Commun. 330: 1132-1137.
39. Hajihosseini, M.K., Wilson, S., De Moerlooze, L., and Dickson, C. 2001. A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. Proc. Natl. Acad. Sci. 98: 3855-3860.
40. Hammes, A., Guo, J.K., Lutsch, G., Leheste, J.R., Landrock, D., Ziegler, U., Gubler, M.C., and Schedl, A. 2001. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 106: 319-329.
41. Hermiston, M.L., Xu, Z., and Weiss, A. 2003. CD45: A critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 21: 107-137.
42. Heyd, F., ten Dam, G., and Moroy, T. 2006. Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative splicing. Nat. Immunol. 7: 859-867.
43. Ho, T.H., Charlet, B.N., Poulos, M.G., Singh, G., Swanson, M.S., and Cooper, T.A. 2004. Muscleblind proteins regulate alternative splicing. EMBO J. 23: 3103-3112.
44. Ho, T.H., Bundman, D., Armstrong, D.L., and Cooper, T.A. 2005. Transgenic mice expressing CUG-BP1 reproduce splicing misregulation observed in myotonic dystrophy. Hum. Mol. Genet. 14: 1539-1547.
45. Hock, H., Hamblen, M.J., Rooke, H.M., Schindler, J.W., Saleque, S., Fujiwara, Y., and Orkin, S.H. 2004. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431: 1002-1007.
46. Hoffman, B.E. and Lis, J.T. 2000. Pre-mRNA splicing by the essential Drosophila protein B52: Tissue and target specificity. Mol. Cell. Biol. 20: 181-186.
47. Homanics, G.E., Harrison, N.L., Quinlan, J.J., Krasowski, M.D., Rick, C.E., de Blas, A.L., Mehta, A.K., Kist, F., Mihalek, R.M., Aul, J.J., et al. 1999. Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the γ2 subunit of the γ-aminobutyrate type A receptor. Neuropharmacology 38: 253-265.
48. Jensen, K.B., Dredge, B.K., Stefani, G., Zhong, R., Buckanovich, R.J., Okano, H.J., Yang, Y.Y., and Darnell, R.B. 2000. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25: 359-371.
49. Jumaa, H., Wei, G., and Nielsen, P.J. 1999. Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr. Biol. 9: 899-902.
50. Kanaar, R., Roche, S.E., Beall, E.L., Green, M.R., and Rio, D.C. 1993. The conserved pre-mRNA splicing factor U2AF from Drosophila: Requirement for viability. Science 262: 569-573.
51. Kanadia, R.N., Johnstone, K.A., Mankodi, A., Lungu, C., Thornton, C.A., Esson, D., Timmers, A.M., Hauswirth, W.W., and Swanson, M.S. 2003. A muscleblind knockout model for myotonic dystrophy. Science 302: 1978-1980.
52. Kanadia, R.N., Shin, J., Yuan, Y., Beattie, S.G., Wheeler, T.M., Thornton, C.A., and Swanson, M.S. 2006. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl. Acad. Sci. 103: 11748-11753.
53. Karsunky, H., Zeng, H., Schmidt, T., Zevnik, B., Kluge, R., Schmid, K.W., Duhrsen, U., and Moroy, T. 2002. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat. Genet. 30: 295-300.
54. Kemp, P.R., Ellis, P.D., and Smith, C.W. 2005. Visualization of alternative splicing in vivo. Methods 37: 360-367.
55. Kim, S., Shi, H., Lee, D.K., and Lis, J.T. 2003. Specific SR proteindependent splicing substrates identified through genomic SELEX. Nucleic Acids Res. 31: 1955-1961.
56. Kozieradzki, I., Kundig, T., Kishihara, K., Ong, C.J., Chiu, D., Wallace, V.A., Kawai, K., Timms, E., Ionescu, J., Ohashi, P., et al. 1997. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45. J. Immunol. 158: 3130-3139.
57. Krawczak, M., Reiss, J., and Cooper, D.N. 1992. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum. Genet. 90: 41-54.
58. Krecic, A.M. and Swanson, M.S. 1999. hnRNP complexes: Composition, structure, and function. Curr. Opin. Cell Biol. 11: 363-371.
59. Ladd, A.N., Stenberg, M.G., Swanson, M.S., and Cooper, T.A. 2005a. Dynamic balance between activation and repression regulates premRNA alternative splicing during heart development. Dev. Dyn. 233: 783-793.
60. Ladd, A.N., Taffet, G., Hartley, C., Kearney, D.L., and Cooper, T.A. 2005b. Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol. Cell. Biol. 25: 6267-6278.
61. Laity, J.H., Chung, J., Dyson, H.J., and Wright, P.E. 2000. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes. Biochemistry 39: 5341-5348.
62. Lemaire, R., Prasad, J., Kashima, T., Gustafson, J., Manley, J.L., and Lafyatis, R. 2002. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: A novel function for SR proteins. Genes & Dev. 16: 594-607.
63. Lewis, B.P., Green, R.E., and Brenner, S.E. 2003. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. 100: 189-192.
64. Lin, X., Miller, J.W., Mankodi, A., Kanadia, R.N., Yuan, Y., Moxley, R.T., Swanson, M.S., and Thornton, C.A. 2006. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15: 2087-2097.
65. Lindgren, N., Usiello, A., Goiny, M., Haycock, J., Erbs, E., Greengard, P., Hokfelt, T., Borrelli, E., and Fisone, G. 2003. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc. Natl. Acad. Sci. 100: 4305-4309.
66. Longman, D., Johnstone, I.L., and Caceres, J.F. 2000. Functional characterization of SR and SR-related genes in Caenorhabditis elegans. EMBO J. 19: 1625-1637.
67. Lynch, K.W. 2004. Consequences of regulated pre-mRNA splicing in the immune system. Nat. Rev. Immunol. 4: 931-940.
68. Lynch, K.W. and Weiss, A. 2000. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol. Cell. Biol. 20: 70-80.
69. Maniatis, T. and Tasic, B. 2002. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418: 236-243.
70. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M., and Thornton, C.A. 2000. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289: 1769-1773.
71. Mankodi, A., Urbinati, C.R., Yuan, Q.P., Moxley, R.T., Sansone, V., Krym, M., Henderson, D., Schalling, M., Swanson, M.S., and Thornton, C.A. 2001. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 10: 2165-2170.
72. Mankodi, A., Takahashi, M.P., Jiang, H., Beck, C.L., Bowers, W.J., Moxley, R.T., Cannon, S.C., and Thornton, C.A. 2002. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10: 35-44.
73. Matlin, A.J., Clark, F., and Smith, C.W. 2005. Understanding alternative splicing: Toward a cellular code. Nat. Rev. Mol. Cell Biol. 6: 386-398.
74. Miller, J.W., Urbinati, C.R., Teng-Umnuay, P., Stenberg, M.G., Byrne, B.J., Thornton, C.A., and Swanson, M.S. 2000. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19: 4439-4448.
75. Mollet, I., Barbosa-Morais, N.L., Andrade, J., and Carmo-Fonseca, M. 2006. Diversity of human U2AF splicing factors. FEBS J. 273: 4807-4816.
76. Muro, A.F., Chauhan, A.K., Gajovic, S., Iaconcig, A., Porro, F., Stanta, G., and Baralle, F.E. 2003. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J. Cell Biol. 162: 149-160.
77. Ogilvy, S., Louis-Dit-Sully, C., Cooper, J., Cassady, R.L., Alexander, D.R., and Holmes, N. 2003. Either of the CD45RB and CD45RO isoforms are effective in restoring T cell, but not B cell, development and function in CD45-null mice. J. Immunol. 171: 1792-1800.
78. Oppermann, M., Mizel, D., Huang, G., Li, C., Deng, C., Theilig, F., Bachmann, S., Briggs, J., Schnermann, J., and Castrop, H. 2006. Macula densa control of renin secretion and preglomerular resistance in mice with selective deletion of the B isoform of the Na, K, 2Cl co-transporter. J. Am. Soc. Nephrol. 17: 2143-2152.
79. Oppermann, M., Mizel, D., Kim, S.M., Chen, L., Faulhaber-Walter, R., Huang, Y., Li, C., Deng, C., Briggs, J., Schnermann, J., et al. 2007. Renal function in mice with targeted disruption of the A isoform of the Na-K-2Cl co-transporter. J. Am. Soc. Nephrol. 18: 440-448.
80. Orr-Urtreger, A., Bedford, M.T., Burakova, T., Arman, E., Zimmer, Y., Yayon, A., Givol, D., and Lonai, P. 1993. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol. 158: 475-486.
81. Pascual, M., Vicente, M., Monferrer, L., and Artero, R. 2006. The Muscleblind family of proteins: An emerging class of regulators of developmentally programmed alternative splicing. Differentiation 74: 65-80.
82. 2+-ATPase isoform 2 (SERCA2) gene. J. Biol. Chem. 274: 2556-2562.
83. Peters, K., Werner, S., Liao, X., Wert, S., Whitsett, J., and Williams, L. 1994. Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. EMBO J. 13: 3296-3301.
84. Philipps, D., Celotto, A.M., Wang, Q.Q., Tarng, R.S., and Graveley, B.R. 2003. Arginine/serine repeats are sufficient to constitute a splicing activation domain. Nucleic Acids Res. 31: 6502-6508.
85. Potashkin, J., Naik, K., and Wentz-Hunter, K. 1993. U2AF homolog required for splicing in vivo. Science 262: 573-575.
86. Revest, J.M., Spencer-Dene, B., Kerr, K., De Moerlooze, L., Rosewell, I., and Dickson, C. 2001. Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev. Biol. 231: 47-62.
87. Ring, H.Z. and Lis, J.T. 1994. The SR protein B52/SRp55 is essential for Drosophila development. Mol. Cell. Biol. 14: 7499-7506.
88. Roshon, M.J. and Ruley, H.E. 2005. Hypomorphic mutation in hnRNP U results in post-implantation lethality. Transgenic Res. 14: 179-192.
89. Rothrock, C., Cannon, B., Hahm, B., and Lynch, K.W. 2003. A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45. Mol. Cell 12: 1317-1324.
90. Rothrock, C.R., House, A.E., and Lynch, K.W. 2005. HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J. 24: 2792-2802.
91. Rudner, D.Z., Kanaar, R., Breger, K.S., and Rio, D.C. 1996. Mutations in the small subunit of the Drosophila U2AF splicing factor cause lethality and developmental defects. Proc. Natl. Acad. Sci. 93: 10333-10337.
92. Ruiz, P., Wiles, M.V., and Imhof, B.A. 1995. Alpha 6 integrins participate in pro-T cell homing to the thymus. Eur. J. Immunol. 25: 2034-2041.
93. Savkur, R.S., Philips, A.V., and Cooper, T.A. 2001. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29: 40-47.
94. Sazani, P., Gemignani, F., Kang, S.H., Maier, M.A., Manoharan, M., Persmark, M., Bortner, D., and Kole, R. 2002. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20: 1228-1233.
95. Schaal, T.D. and Maniatis, T. 1999. Selection and characterization of pre-mRNA splicing enhancers: Identification of novel SR protein-specific enhancer sequences. Mol. Cell. Biol. 19: 1705-1719.
96. Schaefer, T.S., Sanders, L.K., and Nathans, D. 1995. Cooperative transcriptional activity of Jun and Stat3 β, a short form of Stat3. Proc. Natl. Acad. Sci. 92: 9097-9101.
97. Schwerk, C. and Schulze-Osthoff, K. 2005. Regulation of apoptosis by alternative pre-mRNA splicing. Mol. Cell 19: 1-13.
98. Sheives, P. and Lynch, K.W. 2002. Identification of cells deficient in signaling-induced alternative splicing by use of somatic cell genetics. RNA 8: 1473-1481.
99. 35. Mol. Cell. Biol. 22: 221-230.
100. Singer, J.H., Talley, E.M., Bayliss, D.A., and Berger, A.J. 1998. Development of glycinergic synaptic transmission to rat brain stem motoneurons. J. Neurophysiol. 80: 2608-2620.
101. Singh, S., Mishra, R., Arango, N.A., Deng, J.M., Behringer, R.R., and Saunders, G.F. 2002. Iris hypoplasia in mice that lack the alternatively spliced Pax6(5a) isoform. Proc. Natl. Acad. Sci. 99: 6812-6815.
102. Srebrow, A. and Kornblihtt, A.R. 2006. The connection between splicing and cancer. J. Cell Sci. 119: 2635-2641.
103. Stalmans, I., Ng, Y.S., Rohan, R., Fruttiger, M., Bouche, A., Yuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S., et al. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109: 327-336.
104. Tacke, R. and Manley, J.L. 1999. Determinants of SR protein specificity. Curr. Opin. Cell Biol. 11: 358-362.
105. Takahashi, N., Chernavvsky, D.R., Gomez, R.A., Igarashi, P., Gitelman, H.J., and Smithies, O. 2000. Uncompensated polyuria in a mouse model of Bartter's syndrome. Proc. Natl. Acad. Sci. 97: 5434-5439.
106. Tan, M.H., Sun, Z., Opitz, S.L., Schmidt, T.E., Peters, J.H., and George, E.L. 2004. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 104: 11-18.
107. Timchenko, N.A., Welm, A.L., Lu, X., and Timchenko, L.T. 1999. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPβ mRNA and regulates translation of C/EBPβ isoforms. Nucleic Acids Res. 27: 4517-4525.
108. Timchenko, N.A., Cai, Z.J., Welm, A.L., Reddy, S., Ashizawa, T., and Timchenko, L.T. 2001. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 276: 7820-7826.
109. Timchenko, N.A., Patel, R., Iakova, P., Cai, Z.J., Quan, L., and Timchenko, L.T. 2004. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem. 279: 13129-13139.
110. Trede, N.S., Medenbach, J., Damianov, A., Hung, L.H., Weber, G.J., Paw, B.H., Zhou, Y., Hersey, C., Zapata, A., Keefe, M., et al. 2007. Network of coregulated spliceosome components revealed by zebrafish mutant in recycling factor p110. Proc. Natl. Acad. Sci. 104: 6608-6613.
111. Ule, J., Ule, A., Spencer, J., Williams, A., Hu, J.S., Cline, M., Wang, H., Clark, T., Fraser, C., Ruggiu, M., et al. 2005. Nova regulates brainspecific splicing to shape the synapse. Nat. Genet. 37: 844-852.
112. Usiello, A., Baik, J.H., Rouge-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P.V., and Borrelli, E. 2000. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408: 199-203.
113. van der Flier, A., Kuikman, I., Baudoin, C., van der Neut, R., and Sonnenberg, A. 1995. A novel β 1 integrin isoform produced by alternative splicing: Unique expression in cardiac and skeletal muscle. FEBS Lett. 369: 340-344.
114. Venables, J.P. 2004. Aberrant and alternative splicing in cancer. Cancer Res. 64: 7647-7654.
115. 2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ. Res. 89: 838-846.
116. Vrhovski, B., Lemckert, F., and Gunning, P. 2004. Modification of the tropomyosin isoform composition of actin filaments in the brain by deletion of an alternatively spliced exon. Neuropharmacology 47: 684-693.
117. Wang, H.Y., Xu, X., Ding, J.H., Bermingham Jr., J.R., and Fu, X.D. 2001. SC35 plays a role in T cell development and alternative splicing of CD45. Mol. Cell 7: 331-342.
118. Wang, J., Takagaki, Y., and Manley, J.L. 1996. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes & Dev. 10: 2588-2599.
119. Wang, Y., Xu, R., Sasaoka, T., Tonegawa, S., Kung, M.P., and Sankoorikal, E.B. 2000. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J. Neurosci. 20: 8305-8314.
120. Williams, J.H., Sirsi, S.R., Latta, D.R., and Lutz, G.J. 2006. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers. Mol. Ther. 14: 88-96.
121. Williamson, D.J., Banik-Maiti, S., DeGregori, J., and Ruley, H.E. 2000. hnRNP C is required for postimplantation mouse development but is dispensable for cell viability. Mol. Cell. Biol. 20: 4094-4105.
122. Xu, R., Parlow, A.F., and Wang, Y. 2002. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor. Brain Res. 939: 95-99.
123. Xu, X. and Fu, X.D. 2005. Conditional knockout mice to study alternative splicing in vivo. Methods 37: 387-392.
124. Xu, X., Yang, D., Ding, J.H., Wang, W., Chu, P.H., Dalton, N.D., Wang, H.Y., Bermingham Jr., J.R., Ye, Z., Liu, F., et al. 2005. ASF/SF2-regulated CaMKIIδ alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120: 59-72.
125. Yeo, G., Holste, D., Kreiman, G., and Burge, C.B. 2004. Variation in alternative splicing across human tissues. Genome Biol. 5: R74.
126. Yoo, J.Y., Huso, D.L., Nathans, D., and Desiderio, S. 2002. Specific ablation of Stat3β distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock. Cell 108: 331-344.
127. Zeng, H., Yucel, R., Kosan, C., Klein-Hitpass, L., and Moroy, T. 2004. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 23: 4116-4125.
128. Zorio, D.A. and Blumenthal, T. 1999. U2AF35 is encoded by an essential gene clustered in an operon with RRM/cyclophilin in Caenorhabditis elegans. RNA 5: 487-494.